Back

MACROS-2: RCT of ESC 0/1 versus 0/3 hour ADP for suspected ACS

31 August 2025 (17:30 - 17:45)
Organised by: Logo
Congress Presentation Part of: Late-Breaking Clinical Trials: coronary artery disease and interventions Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor James Hatherley

Liverpool University Hospitals NHS Trust, Liverpool (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Complete revascularisation versus usual care in non-STEMI with multivessel disease: results from the SLIM study
Mr T. Pustjens (Maastricht, NL)
Slides Video
Presentation thumbnail
PANTHER - P2Y12 inhibitor or Aspirin moNoTHERapy as secondary prevention in patients with coronary artery disease
Professor M. Valgimigli (Lugano, CH)
Slides Video
Presentation thumbnail
PIONEER IV trial primary report
Professor P. Serruys (Galway, IE)
Slides Video

Access the full session

Session thumbnail
Late-Breaking Clinical Trials: coronary artery disease and interventions
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 17:30 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: coronary artery disease and interventions
thumbnail
Congress Presentation
To agree, or to disagree, that is the question (when applying European Society of Cardiology single-sample diagnostic criteria to four high-sensitivity cardiac troponin assays)
thumbnail
Congress Presentation
Clinical validation of a point of care whole blood high sensitive cardiac troponin I assay: a prospective real time study on 3306 consecutive presentations with suspected acute coronary syndrome

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources